News 17 abr 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
News 24 jan 2024 Odne secures fifth investment from the Dental Innovation Alliance The North American venture capital firm Dental Innovation Alliance has made a fifth investment in Odne. This will support the market launch of an...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
News 27 out 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News 21 nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
News 18 out 2023 Siegfried and Lonza secure top positions in global pharmaceutical outsourcing rankings Valais-based pharmaceutical companies Lonza and Siegfried have been recognized among the leading players in the global outsourcing landscape, wit...
News 04 out 2023 US health agency links up with the Paul Scherrer Institute Researchers from the Paul Scherrer Institute are working on an efficient method of mapping the brain of a mouse. As part of the BRAIN Initiative,...
Aktuell 21 nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
News 26 abr 2023 Siegfried breaks ground on new global R&D Center for Drug Substances in Evionnaz Siegfried will create a new global R&D Center in Evionnaz, investing CHF 25 million to boost capacity, drive growth, and leading to the creation ...